company background image
VICO logo

Vicore Pharma Holding OM:VICO Stock Report

Last Price

kr15.00

Market Cap

kr1.7b

7D

-5.5%

1Y

-7.7%

Updated

27 Mar, 2024

Data

Company Financials +

Vicore Pharma Holding AB (publ)

OM:VICO Stock Report

Market Cap: kr1.7b

VICO Stock Overview

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases.

VICO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Vicore Pharma Holding AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vicore Pharma Holding
Historical stock prices
Current Share Pricekr15.00
52 Week Highkr26.90
52 Week Lowkr12.36
Beta0.78
1 Month Change10.46%
3 Month Change3.73%
1 Year Change-7.75%
3 Year Change-43.40%
5 Year Change-9.64%
Change since IPO111.27%

Recent News & Updates

Vicore Pharma Holding (STO:VICO) Is In A Good Position To Deliver On Growth Plans

Feb 10
Vicore Pharma Holding (STO:VICO) Is In A Good Position To Deliver On Growth Plans

Recent updates

Vicore Pharma Holding (STO:VICO) Is In A Good Position To Deliver On Growth Plans

Feb 10
Vicore Pharma Holding (STO:VICO) Is In A Good Position To Deliver On Growth Plans

We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

Sep 21
We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

May 25
We Think Vicore Pharma Holding (STO:VICO) Needs To Drive Business Growth Carefully

Calculating The Intrinsic Value Of Vicore Pharma Holding AB (publ) (STO:VICO)

Jan 10
Calculating The Intrinsic Value Of Vicore Pharma Holding AB (publ) (STO:VICO)

Is Vicore Pharma Holding (STO:VICO) In A Good Position To Invest In Growth?

Nov 13
Is Vicore Pharma Holding (STO:VICO) In A Good Position To Invest In Growth?

Here's Why We're Watching Vicore Pharma Holding's (STO:VICO) Cash Burn Situation

Jul 26
Here's Why We're Watching Vicore Pharma Holding's (STO:VICO) Cash Burn Situation

Is Vicore Pharma Holding AB (publ) (STO:VICO) Worth kr17.6 Based On Its Intrinsic Value?

Mar 03
Is Vicore Pharma Holding AB (publ) (STO:VICO) Worth kr17.6 Based On Its Intrinsic Value?

What You Need To Know About Vicore Pharma Holding AB (publ)'s (STO:VICO) Investor Composition

Jan 11
What You Need To Know About Vicore Pharma Holding AB (publ)'s (STO:VICO) Investor Composition

Shareholder Returns

VICOSE BiotechsSE Market
7D-5.5%1.4%1.8%
1Y-7.7%6.3%19.0%

Return vs Industry: VICO underperformed the Swedish Biotechs industry which returned 6.3% over the past year.

Return vs Market: VICO underperformed the Swedish Market which returned 19% over the past year.

Price Volatility

Is VICO's price volatile compared to industry and market?
VICO volatility
VICO Average Weekly Movement6.7%
Biotechs Industry Average Movement8.6%
Market Average Movement6.0%
10% most volatile stocks in SE Market12.7%
10% least volatile stocks in SE Market3.4%

Stable Share Price: VICO has not had significant price volatility in the past 3 months.

Volatility Over Time: VICO's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200024Ahmed Mousahttps://www.vicorepharma.com

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company’s portfolio includes idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) diseases. The company develops C21, a low molecular weight angiotensin II type 2 receptor agonist ATRAG; Almee, an investigational medical device in clinical development to address the psychological impact of living with pulmonary fibrosis; Inhaled IMID for the severe cough associated with IPF; and C103, C111, and C112.

Vicore Pharma Holding AB (publ) Fundamentals Summary

How do Vicore Pharma Holding's earnings and revenue compare to its market cap?
VICO fundamental statistics
Market capkr1.68b
Earnings (TTM)-kr310.94m
Revenue (TTM)n/a

0.0x

P/S Ratio

-5.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VICO income statement (TTM)
Revenuekr0
Cost of Revenuekr0
Gross Profitkr0
Other Expenseskr310.94m
Earnings-kr310.94m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 03, 2024

Earnings per share (EPS)-2.78
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did VICO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.